Corporate Overview

Print Page Print Page        E-mail Page Email Page        RSS Feeds RSS        E-mail Alerts Email Alerts        Financial Tear Sheet Tear Sheet
Corporate ProfileAlkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and manufacturing facilities in Gainesville, Georgia and Wilmington, Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.
Stock Quote
ALKS (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$28.91
Change (%) Stock is Down 1 (3.34%)
Volume814,139
Data as of 06/19/13 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote »
News Releases
DateTitle 
05/31/13Alkermes Presents Positive Results from Phase 2 Clinical Study of ALKS 5461 in Major Depressive Disorder at 53rd Annual NCDEU MeetingPrinter Friendly Version
05/29/13Alkermes’ Corporate Presentation to be Webcast at Two Upcoming ConferencesPrinter Friendly Version
05/28/13Alkermes Presents Positive Results from Phase 1 Study of ALKS 3831 as a Broad Spectrum Treatment for SchizophreniaPrinter Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
FirmAnalystPhone
Bank of America/Merrill LynchSteve Byrne646.855.5746
Citi ResearchJonathan Eckard212.816.1441
Cowen & Co.Anant  Padmanabhan646.562.1374
Goldman Sachs & Co.Terence Flynn212.357.5057
Jefferies & Co., Inc.Corey Davis212.336.7187
JPMorgan Securities, Inc.Cory Kasimov212.622.5266
Lazard Capital MarketsWilliam Tanner212.632.1512
Leerink SwannMichael Schmidt617.918.4588
Mizuho SecuritiesMario Corso617.235.1742
MKM PartnersJon LeCroy203.340.5174
Morgan Stanley ResearchDavid Risinger212.761.6494
UBS Investment ResearchAmi Fadia212.713.3242

Alkermes plc is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Alkermes plc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Alkermes plc or its management. Alkermes plc does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

For easy reference, we list below answers to many of the questions we hear most often.

1.Where is Alkermes incorporated?
2.What exchange is Alkermes stock listed on? What is Alkermes' stock symbol?
3.What is Alkermes' CUSIP #?
4.Where is Alkermes' headquarters?
5.Can I purchase shares directly from the company?
6.Who is Alkermes' transfer agent?
7.I've lost my stock certificates; how can I replace them?
8.I'm a shareholder; who should I notify of a change of address?
9.What is Alkermes' fiscal year?
1.Where is Alkermes incorporated?
 Alkermes plc is incorporated in Dublin, Ireland.

2.What exchange is Alkermes stock listed on? What is Alkermes' stock symbol?
 Alkermes is listed on the NASDAQ Stock Exchange under the ticker symbol ALKS.

3.What is Alkermes' CUSIP #?
 The CUSIP # for Alkermes' securities is G01767 105

4.Where is Alkermes' headquarters?
 Alkermes plc is headquartered in Dublin, Ireland. The company also has an R&D center in Waltham, Massachusetts and manufacturing facilities in Athlone, Ireland; Gainesville, Georgia; and Wilmington, Ohio.

5.Can I purchase shares directly from the company?
 No. Alkermes does not have a direct stock purchase plan. You may purchase shares of Alkermes through a broker.

6.Who is Alkermes' transfer agent?
 Alkermes' transfer agent is Computershare (formerly Equiserve Trust company). You can reach Computershare at:

Computershare
P.O. Box 43010
Providence, RI 02940-3010
Phone: (781) 575-2879

7.I've lost my stock certificates; how can I replace them?
 In the event that you lose your stock certificates, you should contact our transfer agent, Computershare (formerly Equiserve Trust Company). You can reach Computershare at:

Computershare
P.O. Box 43010
Providence, RI 02940-3010
Phone: (781) 575-2879

8.I'm a shareholder; who should I notify of a change of address?
 If you change your address, you should contact our transfer agent, Computershare (formerly Equiserve Trust Company). You can reach Computershare at:

Computershare
P.O. Box 43010
Providence, RI 02940-3010
Phone: (781) 575-2879

9.What is Alkermes' fiscal year?
 Alkermes' fiscal year begins April 1 and ends March 31 each year. The quarterly breakdown is as follows:

  • Q1 April 1 - June 30

  • Q2 July 1 - September 30

  • Q3 October 1 - December 31

  • Q4 January 1 - March 31

  • At Alkermes, company policies and procedures provide structure for our operation and ensure that we base our decisions on our shareholders' best interests.

    Committee Charters
    Download Corporate Governance DocumentationAudit and Risk
    Download Corporate Governance DocumentationCompensation
    Download Corporate Governance DocumentationNominating and Corporate Governance
    Compliance Programs
    Download Corporate Governance DocumentationCompliance Program
    Governance Documents
    Download Corporate Governance DocumentationWhistleblower No Retaliation Policy
    Download Corporate Governance DocumentationAudit and Non-Audit Services Pre-Approval Policy
    Download Corporate Governance DocumentationLead Independent Director
    Download Corporate Governance DocumentationCorporate Governance Guidelines
    As of: May 2013
    Download Corporate Governance DocumentationCode of Business Conduct and Ethics

    Committee Composition

    Click on the above graphic to enlarge.

    NASDAQ

    Stock Quote

    ALKS (Common Stock)
    ExchangeNASDAQ (US Dollar)
    Price$28.91
    Change (%) Stock is Down 1 (3.34%)
    Volume814,139
    Data as of 06/19/13 4:00 p.m. ET
    Minimum 20 minute delay
    Refresh quote

    E-mail Alerts